The mechanism of in-stent restenosis in radius stent - An experimental porcine study

Circulation Journal

Volumn 69, Issue 4, 2005, Pages 481-487

  Iso, Yoshitaka ^a   Suzuki, Hiroshi ^a   Sato, Takatoshi ^a   Shoji, Makoto ^a   Shibata, Masayuki ^a   Shimizu, Nobuyuki ^b   Koba, Shinji ^a   Geshi, Eiichi ^a   Katagiri, Takashi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Extracellular matrix; Radius stent; Restenosis; Tenascin C

Indexed keywords

MESSENGER RNA; TENASCIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTICLE; CELL DENSITY; CORONARY STENT; EXTRACELLULAR MATRIX; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEFT CORONARY ARTERY; MACROPHAGE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; ULTRASOUND;

ANIMALS; CORONARY RESTENOSIS; CORONARY VESSELS; EXTRACELLULAR MATRIX; GRAFT OCCLUSION, VASCULAR; IMMUNOHISTOCHEMISTRY; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; RNA, MESSENGER; STENTS; SWINE; TENASCIN; TUNICA INTIMA; UP-REGULATION;

EID: 17044412711     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.481     Document Type: Article

References (29)

1. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? Circulation 2004; 109: 701-705.
2. Angiolillo DJ, Sabata M, Alfonso F, Macaya C. "Candy wrapper" effect after drug-eluting stent implantation: Deja vu or stumbling over the same stone again? Catheter Cardiovasc Interv 2004; 61: 387-391.
3. Suzuki J, Ito H, Gotoh R, Morishita R, Egashira K, Isobe M. Initial clinical cases of the use of a NF-κβ decoy at the site of coronary stenting for the prevention of restenosis. Circ J 2004; 68: 270-271.
4. Kandzari DE, Goldberg S, Schwartz RS, Chazin-Caldie M, Sketch MH Jr, SCORES SVG Registry Investigators. Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: The Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry. Am Heart J 2003; 145: 868-874.
5. Kinoshita Y, Suzuki T, Hosokawa H, Yokoya K. Usefulness of the symphony nitinol stent for arteriosclerosis obliterans. Circ J 2002; 66: 1000-1002.
6. Kobayashi Y, Honda Y, Christie GL, Teirstein PS, Bailey SR, Brown CL 3rd, et al. Long-term vessel response to a self-expanding coronary stent: A serial volumetric intravascular ultrasound analysis from the ASSURE Trial: A Stent vs Stent Ultrasound Remodeling Evaluation. J Am Coll Cardiol 2001; 37: 1329-1334.
7. Carter AJ, Scott D, Laird JR, Bailey L, Kovach JA, Hoopes TG, et al. Progressive vascular remodeling and reduced neointimal formation after placement of a thermoelastic self-expanding nitinol stent in an experimental model. Cathet Cardiovasc Diagn 1998; 44: 193-201.
8. Taylor AJ, Gorman PD, Kenwood B, Hudak C, Tashko G, Virmani R. A comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine model. Catheter Cardiovasc Interv 2001; 53: 420-425.
9. Chiquet-Ehrismann R, Tannheimer M, Koch M, Brunner A, Spring J, Martin D, et al. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol 1994; 127: 2093-2101.
10. Yorozuya M, Suzuki H, Iso Y, Shibata M, Nakatani M, Koba S, et al. Comparison of the morphological changes of restenosis after the implantation of various types of stents in a swine model. Coron Artery Dis 2002; 13: 305-312.
11. Geffrotin C, Horak V, Crechet F, Tricaud Y, Lethias C, Vincent-Naulleau S, et al. Opposite regulation of tenascin-C and tenascin-X in MeLiM swine heritable cutaneous malignant melanoma. Biochim Biophys Acta 2000; 1524: 196-202.
12. Wang JF, Olson ME, Reno CR, Kulyk W, Wright JB, Hart DA. Molecular and cell biology of skin wound healing in a pig model. Connect Tissue Res 2000; 41: 195-211.
13. Sigmond J, Kroep JR, Loves W, Codacci-Pisanelli G, Peters GJ. Quantitative real time PCR of deoxycytidine kinase mRNA by light cycler PCR in relation to enzyme activity and gemcitabine sensitivity. Cancer Lett 2004; 213: 173-179.
14. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-230.
15. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99: 44-52.
16. Thierry B, Merhi Y, Bilodeau L, Trepanier C, Tabrizian M. Nitinol versus stainless steel stents: Acute thrombogenicity study in an ex vivo porcine model. Biomaterials 2002; 23: 2997-3005.
17. Sheth S, Litvack F, Dev V, Fishbein MC, Forrester JS, Eigler N. Subacute thrombosis and vascular injury resulting from slotted-tube nitinol and stainless steel stents in a rabbit carotid artery model. Circulation 1996; 94: 1733-1740.
18. Chung IM, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 2002; 40: 2072-2081.
19. Glover C, Ma X, Chen YX, Miller H, Veinot J, Labinaz M, et al. Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation. Am Heart J 2002; 144: 702-709.
20. Imanaka-Yoshida K, Matsuura R, Isaka N, Nakano T, Sakakura T, Yoshida T. Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: Clinical significance of early tenascin-C expression. Virchows Arch 2001; 439: 185-190.
21. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986; 47: 131-139.
22. Imanaka-Yoshida K, Matsumoto K, Hara M, Sakakura T, Yoshida T. The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation 2003; 71: 291-298.
23. Kajiwara K, Ueda H, Yamamoto H, Imazu M, Hayashi Y, Kohno N. Tenascin-C is associated with coronary plaque instability in patients with acute coronary syndromes. Circ J 2004; 68: 198-203.
24. Wallner K, Li C, Shah PK, Fishbein MC, Forrester JS, Kaul S, et al. Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. Circulation 1999; 99: 1284-1289.
25. Feng Y, Yang JH, Huang H, Kennedy SP, Turi TG, Thompson JF, et al. Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells. Circ Res 1999; 85: 1118-1123.
26. Chiquet M, Renedo AS, Huber F, Fluck M. How do fibroblasts translate mechanical signals into changes in extracellular matrix production? Matrix Biol 2003; 22: 73-80.
27. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1 beta. Circulation 2000; 101: 1319-1323.
28. Iso Y, Suzuki H, Satou T, Shoji M, Shimizu N, Shibata M, et al. Local delivery of a specific Rho-kinase inhibitor suppressed vascular remodeling after balloon angioplasty in porcine coronary arteries. Circ J 2002; 66(Suppl 1): 499.
29. Matsumoto Y, Uwatoku T, Oi K, Abe K, Hattori T, Morishige K, et al. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: Involvement of multiple mechanisms. Arterioscler Thromb Vasc Biol 2004; 24: 181-186.